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ABSTRACT 
Introduction: Dysmenorrhea is menstrual pain in such circumstances where great, forcing the patient to 
rest and leave the work or its way of life everyday, for several hours or several days (Simanjuntak, 2007). 
In Indonesia, menstrual cramps affect approximately 55% of menstruating women of childbearing age 
and 10% of them had severe symptoms that require bed rest. Noni (Morindacitrifolia L) is a fruit 
containing complete nutrition. Noni functioning as an analgesic has been known in the history of 
traditional medicine, so that’s what makes this plant is called "painkiller tree" or "headache tree". The 
purpose of this research was to find out the effect of Noni juice (Morindacitrifolia) on the reduction of 
menstrual cramps. Methods: The research employed Pre Experiment One - Group pre - post test design. 
The population of this study was teenage students in the Department of Nursing, Health Polytechnic of 
Malang, Ministry of Health of Indonesia, and in STIKES Kendedes who experienced menstrual cramps 
(dysmenorrhea).To ensure that the samples represented the population, the techniques of consecutive 
sampling and random sampling were employed to select those who experienced menstrual cramps 
between the months of July and November 2014. The sample size was 25 teenage students. Noni juice 
was made from selected noni fruits that were unripe, fresh, green and hard and processed in the 
laboratory. The instrument used to assess the level of cramping pains (dysmenorrhea) was questionnaires 
using Descriptive Verbal Scale (VDS), which consisted of 6 levels of pain. Results: The results showed 
that before the treatment, the level of cramping pain of 17 respondents was moderate (68%, N = 25) and 
that of 7 respondents was severe (28%, N = 25). After the treatment, 18 respondents (72%, N = 25) did 
not experience cramping pain at all and 6 respondents (24%, N = 25) experienced mild pain. The 
statistical analysis using Wilcoxon test indicated that there was significant difference in the average rates 
of cramping pains before and after the treatment (p = 0.000). Conclusion: This suggested that noni juice 
could significantly reduce the cramping pains of menstruating teenage girls. 
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INTRODUCTION 
Noni (Morinda citrifolia L) fruit is a 
nutritionally complete food. Nutrients that the 
body needs -among others are carbohydrates, 
protein, vitamins, and essential minerals- are 
also available in noni fruit and leaves. Most of 
the indigenous Polynesian cultures of the past 
and present, have been using noni as their staple 
food. Native of South Pacific islands consume 
noni fruit to survive in a time of famine. 
(Magdalena, 2011). 
Noni fruit ability as an analgesic has 
been known in the history of traditional 
medicine, so that the plant is called as 
"painkiller tree" or "headache tree". Scientific 
research has proven the beneficial effects of 
Noni to overcome the pain. In 1990, researchers 
found a significant relationship between the dose 
of extract of Noni juice with analgesic activity 
on guinea pigs. Generally, the more widely used, 
the analgesic effect will be stronger. 
(Magdalena, 2011). 
Studies and research on Noni continues 
to be done by various research institutions and 
universities. Dr.Ralph Heinicke (1972), a 
famous biochemist from the United States found 
out that the Noni fruit contains xeronine and its 
precursor (proxeronine) in large numbers. 
Proxeronine is a type of colloid acid that does 
not contain sugar, amino acids or nucleic acids 
such as other colloids with a relatively large 
molecular weight, more than 16.000. By taking 
proxeronine, the xeronine levels in the body will 
increase. In the human body, proxeronase 
enzymes and other substances will turn 
proxeronine into xeronine. Xeronine is one of 
the important substances that regulate specific 
functions of proteins and cells of the human 
body. Normally, proxeronine is stored in the 
liver and are periodically released into the 
bloodstream to be absorbed by the organ as 
needed. Human tissue cells contain receptors, a 
binding with xeronine. In the process of pain, 
xeronine changing receptor proteins in the brain 
to be activated to bind endorphins. Endorphin is 
an endogenous opioid polypeptide that functions 
as a neurotransmitter, is produced by the 
pituitary gland and the hypothalamus as an anti-
pain. 
In 1993, University of Hawaii 
researchers managed to separate substances of 
Noni scopoletin. These substances have 
medicinal properties, and experts believe that 
scopoletin is one of the substances contained in 
Noni fruit that can bind serotonin, one of the 
important chemical substances in the human 
body. Scopoletin serves to widen the blood 
vessels that are narrowed in blood circulation. 
Scopoletin compound (hydroxy-methoxy-
coumarin) is very effective as an anti-
inflammatory. 
Many theories describe the mechanism 
of Noni to relieve pain. One is the theory of Dr. 
Ralph Heinicke (famous biochemist from the 
US) which says that the xeronine plays a role in 
relieving pain. This is associated with the ability 
of xeronine to normalize protein in abnormal 
cells, including cells of brain tissue, the source 
of the pain. Some cases of chronic pain such as 
constant headaches, nerve pain in muscles, and 
joint pain are cured after taking Noni juice. Dr. 
Joseph Betz, a chemical researchers from the 
FDA (Food and Drug Association) division of 
the Natural Products Center For Good Safety 
and Applied Nutrition at the US said that some 
experiments have shown that Noni juice can 
soothe muscle movement (Maria, 2007). 
Pain or tenderness can occur in a variety 
of conditions, such as pain arising during 
menstruation (dysmenorrhea) and joint pain at 
the time of menopause. Dysmenorrhea is 
menstrual pain in such circumstances where 
great, forcing the patient to rest and leave the 
work or its way of life everyday, for several 
hours or several days (Simanjuntak, 2007). The 
incidence of menstrual pain in Indonesia is 
estimated to reach nearly 55% of women of 
childbearing age. They are tormented by pain 
during menstruation and 10% had severe 
symptoms that require bed rest. The incidence of 
primary dysmenorrhea types in Indonesia is 
around 54.89%, while the rest were patients with 
secondary type (Qittun, 2008). 
Dysmenorrhea, or menstrual pain occurs 
because of an imbalance of the progesterone 
hormone in the blood resulting in pain to arise, 
but the symptoms certainly can be associated 
with ovulation. During the luteal phase, there is 
too much release of prostaglandin F2α (PGF2α) 
that can increase uterine contractions and causes 
the uterus arteriolar vasospasm, resulting in 
ischemia and lower abdominal cramps (Bobak, 
2004). The increasing production of 
prostaglandin F2α (PGF2α) and prostaglandin 
E2 (PGE2) or inadequate ratio of PGF2α: PGE2 
can increase tonus uterus rest, myometrium 
contractile pressure, the frequency of uterine 
pressure, and arrhythmic contraction of the 
uterus. These abnormalities will cause 
vasoconstriction, ischemia and hypoxia uterus, 
all of them causes pain. In general, 50-60% of 
women require analgesics drugs to handle 
dysmenorrhea (Riyanto, 2002). 
There are many ways to eliminate or 
reduce pain, pharmacologically by using 
analgesic drugs or non-pharmacological ways to 
eliminate the pain (Long, 1996). The usual 
treatment for reducing pain during menstruation 
is a non-steroidal anti-inflammatory drugs (e.g. 
ibuprofen, naproxen and mefenamic acid). Most 
drugs are anti-inflammatory non-steroidal 
(NSAID), effective in treating primary 
dysmenorrhea in 70-90% of cases, but has side 
effects that can impact negatively. There have 
been not much  research on the use of non-
pharmacological methods that shows high 
effectiveness in reducing menstrual pain 
(Stephenlie, 2004). The use of herbs for the 
treatment has been done, including to noni fruit 
that is believed to have many health benefits. 
Some cases of chronic pain such as continuous 
headache, muscle pain and joint pain are healed 
after consuming Noni juice. Empirically, noni 
fruit also has properties to cope with pain during 
menstruation, but it has never been scientifically 
proven. 
Noni fruit does not give toxic effects in 
experimental done to animals and humans. This 
is evidenced by some of the results below. Bret 
J. West et.al in 2009 continued to do research on 
subcronic hepatotoxicity and toxicity tests of 
noni fruit. The results show that the guinea pigs 
given noni fruit in the form of freeze-dried-strain 
did not show any decrease in its HepG2 cell 
survival, it did not affect the accumulation of 
neutral lipids and phospholipids which is an 
indicator of hepatic cell necrosis, and no 
histopathological changes in liver cells. In this 
study the dose of noni juice was more than 6.86 
g / kg which is equivalent to about 90 ml/kg of 
noni juice.  
In the first phase of the research on the 
effect of noni fruit juice to pain and toxic effects 
that were performed on 36 guinea pigs (Rattus 
norvegicus), the result shows that unripe noni 
fruit juice contains xeronine 1339.254 ppm, 
more than the ripe noni fruit juice, which is 
893.960 ppm, and it is proven to reduce the pain 
response of guinea pigs at the scale of more than 
60% for the ripe noni fruit (dose of 2 ml, 4 ml, 6 
ml per 100 grBW) and over 75% for unripe noni 
fruit (dose of 4 ml / 100 grBW). This indicates 
that noni fruit juice especially the unripe ones is 
highly effective in reducing pain in guinea pigs. 
This study also found out that the administration 
of noni fruit juice did not leave toxic effects in 
guinea pigs that none of the guinea pigs died 
after being given noni fruit juice, even at 
maximum doses (Astutik, 2012). Research on 
the toxicity of noni fruit juice has also been 
performed clinically in 96 respondents aged 18 
s/d 64 years old and showed that the 
administration of Tahitian noni fruit juice up to a 
dose of 750 ml/day is safe or harmless (Davies 
& Mugglestone, 2003). 
Based on the above background,the 
researchers is interested in conducting research 
on the effect of noni fruit juice to a decrease 
pain in menstruation (dysmenorrhea), in the 
hope that the results of this study can be used as 
information material and development of science 
related to the utilization of medicinal 
plants/herbs as an alternative to overcome 
menstrual problems. 
The research problem is: "Is the 
administration of Noni fruit juice (Morinda 
citrifolia L) can reduce menstrual pain?". The 
general objective of this research is: Knowing 
the Effect of Noni Fruit Juice (Morinda 
citrifolia) to decrease menstrual pain, while the 
specific objectives of the research are: (1) to 
identify menstrual pain before given noni fruit 
juice, (2) to identify menstrual pain after given 
the noni fruit juice and ( 3) to analyze the effect 
of noni fruit juice to decrease menstrual pain. 
The benefits of the research are: (1) As a 
reference material or literature development for 
Educational Institutions about the benefits of 
medicinal plants/herbs for health, especially in 
dealing with menstrual pain, (2) To provide 
information to people that Noni juice can be 
used as an alternative to overcome menstrual 
pain and (3) For information or input material 
for further research. 
 
METHODS 
The design of this research is a Pre 
Experiment with One – Group Pre – post test 
Design (Nursalam, 2011). In this study, a pre-
test was conducted to respondents about the 
level of dysmenorrhea before given Noni juice 
(O1) and then given treatment by providing 
Noni juice 3 times daily for 2 days, then a 
second measurement (post-test) was carried out 
on the level Dysmenorrhea on the respondents 
(O1¹). 
The population in this study were all 
teenage girls who experience painful 
menstruation (dysmenorrhea) at Health 
polytechnic of Malang in Nursing Department 
and STIKES Kendedes. The research sample 
(because not all the population menstruate at the 
time of the study) was chosen according to the 
characteristics of the population (Notoatmodjo, 
2010). The sample in this study mostly were 
teenage girls in Health Polytechnic of Malang in  
Nursing Department and STIKES Kendedes 
who experience menstrual pain and meet the 
criteria of the sample during the months of July 
to November 2014. The sample size were 25 
people. 
Sampling technique in this research is 
was a consecutive sampling and random 
sampling method was used to select teenage 
girls who meet the criteria for the sample. 
Criteria for the sample in this study were criteria 
for inclusion, exclusion and resignation. 
Inclusion criteria for the study were: (1) Girls 
who experience primary dysmenorrhea at the 
first day of menstruation and during 
menstruation, (2) Not currently taking 
medication to reduce dysmenorrhea, (3) Does 
not have any disease (infection of the uterus, 
uterine tumors, etc.) or in good health, (4) Does 
not have any allergy to noni, (5) Volunteers and 
no correlation between respondents with 
researchers and (6) Willing to be a respondent. 
Exclusion criteria for the study were: (1) Taking 
drugs or other drinks to reduce pain other than 
noni juice during the study, and (2) 
Experiencing very great menstrual pain. While 
the resignation criteria are: (1) Respondents who 
do not want to continue the study because of its 
side effects or discomfort (nausea / vomiting, 
allergies) and (2) Respondents do not feel the 
benefits of drinking noni juice and still no 
decrease in pain. 
The study was conducted at Health 
Polytechnic of Malang and STIKES Kendedes 
Malang. The research was conducted from July 
to November 2014, while the data collection was 
from September to November 2014. 
The independent variable of the research 
was noni fruit juice administration with 
operational definition of Noni juice 
administration to teenage girls who are 
menstruating and experience menstrual pain 
(Dismenorhea) with a dosage of 9 ml/kg bw per 
day, which is taken 3 times daily for 2 
consecutive days. Meanwhile, the dependent 
variable is the decline of Dysmenorrhea with 
operational definition of pain changes in teenage 
girls at Health Polytechnic of Malang and 
STIKES Kendedes Malang who are 
experiencing dysmenorrhea measured by using 
twice Verbal Descriptive Scale (VDS) on day 1 
and day 2 of menstruation. Measuring tool was 
using a VDS questionnaire with pain category of 
no pain to severe pain pain, and the score is 0 to 
5. 
The material for the research is fresh 
unripe Noni fruit with fruit condition criteria of 
green and hard, which is made in the form of 
fruit juice with the addition of honey sweetener 
as much as 7-8%, with laboratory processing. 
The materials were taken by the researchers 
themselves from the tree and the fruit were 
selected. Compensation will be given to the 
owner of the tree. 
The research instrument used to assess 
the level of pain (dysmenorrhea) is a 
questionnaire using Verbal Descriptive Scale 
(VDS), which consists of 6 levels of pain. 
The procedure of the research consisted 
of two phases. The first stage was the making of 
the product of noni fruit juice in the laboratory 
and analyzing xeronine substances or nutrients 
in the product by way of: (1) Noni fruit is 
processed in the laboratory in the form of juice 
(direction of making it is attached), (2) put the 
juice in a cup/bottle of 150 ml, (3) Do the 
xeronine substances and nutrients analysis on 
the product (4) label the product. Meanwhile, the 
second phase of the research was the provision 
of noni fruit juice products to the respondents. 
Data collecting in this research was 
done through questionnaires, guided interviews, 
and observation. The steps were: (1) Making a 
research permit, (2) Dividing the questionnaire 
for the preliminary study to find out how many 
people experiencing dysmenorrhea, to know 
what they do to handle it and the severity of 
their pain/dysmenorrhea, (3) Conducting guided 
interviews to know the type of dysmenorrhea as 
well as their menstrual cycle, (4) Determining 
respondents based on inclusion criteria that have 
been created are then choosing potential 
respondents randomly, (5) Visiting respondents 
a few days prior to the date of menstruation to 
ensure that the plan will be undertaken, (6) 
Describing the action to be performed, (7) 
Measuring the weight of respondents, (8) 
Preparing the tools and materials necessary for 
action, (9) Requesting approval for becoming 
respondents and (10) Measuring the level of 
dysmenorrhea before the action is taken. 
Meanwhile, the steps for collecting data 
after performing the action were: (1) Measuring 
the level of dysmenorrhea pain of respondents 
after administration of Noni juice for 2 days 
with a dose of 9 ml/ KgBW. Taken 3 times a day 
by using a verbal descriptive scale (VDS), (2 ) 
Measuring the level of pain which was done 
twice a day, on the first day and the second day 
of treatment conducted by two observers, and 
(2) During the treatment, if there is no decline in 
the pain, then a standard therapy will be done. 
During the study, the researchers 
conducted the recording of data on hours/time of 
drinking noni juice, dose, pain response, and 
adverse effects on the sheet when there is a data 
collection / observation sheet. Recording a 
response to pain is done twice after drinking 
noni juice after the first dose and the second 
dose on day two to determine immediately 
whether there is a change against menstrual 
pain. 
Data processing is done with editing, 
coding, scoring and tabulating, and then the data 
is processed and analyzed using statistical test 
Wilcoxon Match Pairs Test. (Sugiyono, 2010). 
This research will be done using error level of 
0.05. If z-count is smaller than z-table then Ho is 
accepted and Ha is rejected.  
The data is presented in the form of a 
frequency distribution table and the results of its 
analysis. Both data -the primary data table and 
the results of the statistical calculations- have 
been analyzed, presented and described in 
tables, they include: (1) The age distribution of 
clients, (2) The weight loss distribution (3) The 
percentage of menstrual pain before action, (4) 
The percentage of menstrual pain after the 
action, and (5) The analysis of dysmenorrhea 
before and after the action. 
This research was conducted with 
respect to research ethics, they are: (1) Informed 
consent (studies approval), (2) The name of the 
research subjects are not included (anonimity) 
on measuring devices sheets and researchers 
only write code in data collection sheets or the 
results of the research that will be presented ( 3) 
The confidentiality of all the information that 
has been collected is guaranteed (4) The 
experiment was conducted without causing 
distress to the subject, especially if it is using a 
special action, and (5) Subject has the right to 
decide if they are willing to be the subject or not, 
in the absence of any sanctions (Right to self-
determination). 
 
RESULT 
Based on the analysis method of 
Chromatography High Performance Liquid 
Chromatography (HPLC) to identify the active 
substance content of noni fruit juice which was 
conducted in the chemical laboratory of the 
Faculty of Mathematics, University of 
Muhammadiyah Malang, it was found out that 
young noni fruit juice contains xeronine (mg / 
100g) belonging to the colloid compound, the 
number of the content is as much as 196.7335 
mg /100g with a dilution of 1: 1. 
Univariate description of the research 
consists of the distribution of the age and weight 
of the respondents are shown in tables 1 and 2 
below. Bivariate description consists of: (1) The 
level of Dysmenorrhea before treatment, (2) The 
level of menstrual pain after treatment and (3) 
Decreased levels of Dysmenorrhea, as shown in 
Table 3 and 4 below and the diagram 1 below. 
 
Table 1. Frequency Distribution of Respondents’ Age in 2014 
No The Age of Respondents (Year) Frequency Percentage 
1. 
2. 
3. 
4 
17 
18 
19 
20 
1 
13 
8 
3 
4.0 
52.0 
32.0 
12.0 
                             Total 25 100.0 
 
Table 2. Frequency Distribution of Respondents’ Body Weight in 2014 
No Body Weight (Kg) Frequency Percentage  
1. 
2. 
3. 
4. 
5. 
6. 
<40 
40-45 
45-50 
50-55 
55-60 
>60 
1 
9 
7 
4 
3 
1 
4.0 
36.0 
28.0 
16.0 
12.0 
4.0 
 
No Body Weight (Kg) Frequency Percentage  
                             Total 25  100.0  
 
Table 3. Frequency Distribution of the level of Dysmenorrhea before treatment in 2014 
No Level of Pain Frequency Percentage  
1. 
2. 
3. 
4. 
5. 
6. 
 No pain 
 Mild pain 
 Moderate pain 
 Intense pain 
 Very intense pain 
 Excruciating pain 
0 
1 
17 
7 
0 
0 
00 
4.0 
68.0 
28.0 
0.0 
0.0 
 
                             Total 25 100.0  
 
Table 4. Frequency Distribution of the level of Dysmenorrhea after treatment in 2014 
No Level of Pain Post test I Post test II  
  Frequency Percentage Frequency Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
 No pain 
 Mild pain 
 Moderate pain 
 Intense pain 
 Very intense pain 
 Excruciating pain  
6 
13 
6 
0 
0 
0 
24.0 
52.0 
24.0 
0 
0 
0 
18 
6 
1 
0 
0 
0 
72.0 
24.0 
4.0 
0.0 
0.0 
0.0 
                             Total  25 100.0 25 100.0 
 
 
 
Figure 1. Graphic of the Average Decrease of Dysmenorrhea Trend on Pretest and Post test 
 
Table 1 shows that most respondents (13 
people/52%) are at the age of 18 years old, while 
Table 2 shows that most respondents (9/36%) in 
the range of 40-45 kg body weight.  
Table 3 shows that the respondents' 
level of menstrual pain before treatment was at 
moderate pain with 17 people (68%),  and 7 
people (28%) were at intense pain. Table 4 
shows that the respondents' level of menstrual 
pain after treatment were at no pain category at 
the highest score (18 people/72%, n = 25) and 
mild pain category with 6 people (24%, n = 25). 
The study found a significant decline in 
pain where the average rate of incidence of pain 
before administration of noni is 2.24, but after 
given the noni juice then the average rate of 
incidence of pain on the post-test respondents on 
the second day was at 0.32. The average 
reduction in pain on the first day was 1.24 and 
on day II was 0.68, as shown in Figure 1 above. 
To determine whether there are any 
differences before and after administration of 
noni, the Wilcoxon statistical test shows the 
following results: 
 
Table 5. Analysis results 
 Post Test – Pre Test 
Z -4.549 
Asymp. Sig. (2-tailed) 0,000 
a.  Based on positive ranks 
b. Wilcoxon Signed Ranks Test 
 
If the probability (Asymp. Sig. (2-
tailed)) <0.05 then there is a difference before 
and after administration of noni. If the 
probability (Asymp. Sig. (2-tailed))> 0.05, then 
there is no difference before and after the 
administration of noni. From the analysis above 
it can be concluded that there is a very 
significant difference before and after the 
administration of noni against menstrual pain, 
this is evidenced by the p-value (0.000) which is 
far below the level of significance (0.05). 
 
DISCUSSION 
Dysmenorrhea level assessment results 
before the teenage girls were given noni fruit 
juice using a verbal descriptive scale (VDS) 
obtained the highest level of pain at the level of 
moderate pain and severe pain. This is possible 
because the process of dysmenorrhea 
experienced by teenage girls is a physiological 
thing where dysmenorrhea, or menstrual pain 
may occur before or during menstruation. Based 
on the data, more than 50% of teenage girls 
often experience the primary Dysmenorrhea. 
Pain in the primary Dysmenorrheaa is caused by 
endometrial prostaglandin containing high 
amounts causing contraction of the myometrium 
that are able to constrict the blood vessels, 
resulting in ischemia, the disintegration of the 
endometrium, bleeding and pain (Morgan, 
2009). 
The intensity of menstrual pain that 
arises is depending on the health and 
psychological condition of the youth. The girls 
who are emotionally unstable, especially if they 
are not well informed on the process of 
menstruation, will be easily experiencing 
dysmenorrhea (Sarwono, 2005).  Similarly, 
constitutional factors can reduce resistance to 
pain. 
The largest age category is at the age of 
18 years (52.0%), this enables teenage girls to 
experience primary dysmenorrhea. Primary 
dysmenorrhea is a menstrual pain with no real 
abnormalities in genital properties. Primary 
dysmenorrhea occurs some time after menarch, 
usually after 12 months or more, because 
menstrual cycles in the first months after 
menarch generally are in anovulator type and not 
accompanied by pain (Sarwono, 2005). It 
usually occurs between the age of 15-25 years 
old and then disappear at the age of late 20s or 
early 30s. Besides it is also common at the age 
of less than 20 years old and usually disappears 
after pregnancy (www.etd.eprints.ums.ac.id). 
Primary dysmenorrhea arises in adolescence, i.e 
2 -3 years after the first period and occurs in less 
than 20 years of age (Anonymous, 2007). 
The pain arises shortly before or 
together with the onset of menstruation and lasts 
a few hours, although in some cases it can take 
several days (Wiknjosastro, 2005). Based on 
interviews during the study, the pain 
experienced by teenage girls in Health 
Polytechnic of Malang and STIKES Kendedes 
Malang is generally for 2 to 3 days prior to and 
at the beginning of menstruation with different 
intensities, ranging from no pain to the most 
severe pain. Some common efforts to overcome 
the pain are by taking analgesics, consuming 
herbal drinks to decrease menstrual pain, doing a 
warm compress on the stomach, pressing the 
stomach with a pillow or making some 
distraction. 
Dysmenorrheal level assessment results 
after the respondent was given juice fruit juice 
using a verbal descriptive scale (VDS) obtained 
the highest level of pain at no pain level (72%) 
and mild pain (24%). This is possible with the 
treatment given where the teenage girls drink 
noni fruit juice with a dose of 9 ml/BW taken 3 
times daily for 2 days which contains the active 
ingredient of xeronine. Based on the analysis 
method of Chromatography High Performance 
Liquid Chromatography (HPLC) to identify the 
active substance content of noni fruit juice done 
in the chemical laboratory of the Faculty of 
Mathematics, University of Muhammadiyah 
Malang, it was found out that unripe noni fruit 
juice contains xeronine (mg / 100g) belonging to 
the colloid compound, the number of the content 
is as much as 196.7335 mg / 100g. 
Xeronin is an alkaloid the human body 
which is needed to activate the enzyme and to 
organize and form the structure of proteins, and 
are analgesic, relieve headaches, and nerve 
muscle pain (Solomon 1998, in Puji Rahayu, 
2006). In the process of pain, xeronine changing 
receptor proteins in the brain become activated 
to bind endorphins. Endorphin is an endogenous 
opioid polypeptide that functions as a 
neurotransmitter, is produced by the pituitary 
gland and the hypothalamus as an anti-pain. 
Waha MG, (2007) describes one 
important alkaloid found in Noni is xeronine. 
Xeronine is produced also by the human body in 
a limited number that serves to activate enzymes 
and regulate the function of proteins in the cell. 
Xeronine was first discovered by Dr. Ralph 
Heinicke (a biochemist). Although the Noni fruit 
contains very little xeronine, but it contains 
ingredients to form (precursor) xeronine, namely 
proxeronine in large quantities. Proxeronine is a 
type of colloid acid that does not contain sugar, 
amino acids or nucleic acids such as other 
colloids with a relatively large molecular weight, 
more than 16.000. When we consume the 
proxeronine, the xeronine levels in the body will 
increase. Normally, proxeronine is stored in the 
liver and are periodically released into the 
bloodstream to be absorbed by the organ as 
needed. Human tissue cells contain receptors, a 
binding with xeronine. In the human body, 
proxeronase enzymes and other substances will 
turn proxeronine into xeronine. The main 
function of xeronine is to regulate the shape and 
rigidity (hardness) of specific proteins present in 
the cell. It is important to remember when these 
proteins function abnormally; the body will 
experience health problems.  
Wilcoxon statistical test analysis results 
show that there is an influence of noni fruit juice 
to decrease pain where there is a significant 
difference from the average reduction in 
menstrual pain levels before and after 
administration of noni juice (p = 0.00). This 
proves that the noni fruit juice at a dose of 9 
ml/bw taken 3 times daily is effective in 
reducing dysmenorrhea in adolescent girls. The 
results of this study supported Solomon’s 
statement (1998) in Puji Rahayu (2006) who 
states that noni fruit contains Xeronin bioactive 
which is an alkaloid the human body which 
needs to activate the enzyme and to organize and 
form the structure of proteins, and are analgesic. 
Menstrual pain usually occurs a few 
hours before or after a menstrual period and can 
continue up to 48-72 hours. Painful menstruation 
(dysmenorrhea) is described as similar-
spasmodic convulsions, localized in the lower 
abdomen (supra-pubic area) and can spread to 
the thighs and lower back, can be accompanied 
by nausea, vomiting, diarrhea, headache, lower 
back pain, irritability, fatigue etc.  
Painful menstruation (primary 
dysmenorrheal) may occur because of 
psychological/stress which causes an increase in 
stress hormones vasopressin and catecholamine 
that occurs because of the imbalance or PGF2α: 
PGE2 causing vasoconstriction of blood vessels 
that cause ischemia and cell damage. This 
causes uterine contractions (disrhytmic) which 
then lead to the perception of pain. Noni 
contains xeronine which has analgesic properties 
and also contains scopoletin which serves to 
widen the narrowing blood vessels and make 
blood circulation better, thus reducing 
disrhytmic contractions that cause the pain. 
The dose given in this study is a dose 
that is safe and non-lethal. This is evidenced by 
the absence of significant complaints from the 
respondents such as diarrhea, vomiting, 
dizziness-headache, etc. 
The results also support previous 
research which say that the first phase of 
research on the effect of noni fruit juice to pain 
and toxic effects which were performed on 36 
guinea pigs (Rattus norvegicus), shows that 
unripe noni fruit juice is proven to reduce pain 
response more than 60 % on guinea pigs with 
ripe noni fruit juice and more than 75% for 
unripe noni fruit. 
Based on the above results, it can be 
concluded that noni has proven its efficacy to 
decrease menstrual pain, therefore noni fruit 
juice can be used as an alternative herbal 
product in reducing menstrual pain, especially 
because it is safe for consumption and easy in 
production. Noni fruit trees are not easy to be 
found and they are usually planted freely and not 
for sale, so that the noni fruit is hard to find on 
the market. The cultivation of noni fruit is 
generally for the treatment of high blood 
pressure or hypertension, therefore this fruit 
needs to be more cultivated to be able to make 
use of the products more. The people are 
expected to take more advantages from this plant 
as an alternative to overcome the problem of 
menstrual pain.  
 
CONCLUSION AND RECOMMENDATION 
Conclusion 
Menstrual pain level before treatment in 
most teenage girls is at the level of moderate 
pain that is 17 people (68%, n = 25) and there 
are 7 people in severe pain (28%, n = 25). While 
most teenage girls feel no menstrual pain after 
treatment (18 people/72%, n = 25) and 6 people 
(24%, n = 25) has mild pain. There are 
significant differences in the average level of 
menstrual pain before and after the 
administration of noni (p = 0.000), so that the 
Noni fruit juice has significant effect in reducing 
the level of menstrual pain in teenage girls. 
 
Recommendation 
For teenage girls with dysmenorrhea, it 
is recommended to consume the unripe Noni 
fruit juice at a dose of 9 ml/KgBW 3 times daily 
as an alternative to reduce menstrual pain. 
Further studies need to be done about the 
phytochemical content and associated 
processing methods using noni as one of the 
herbal products that is safe to reduce menstrual 
pain. Re-cultivation of the noni fruit crops is 
needed. 
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